Search - tctmd.com

Displaying 161 - 180 of 234

Sort: Relevancy | Date

Presentation TCT 2013

Flash Lecture #2: Renal Denervation: Summary of Clinical Evidence

Presenter: Henrique Carvalho

October 30, 2013

Presentation TCT 2013

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Presenter: Krishna Rocha-Singh

October 30, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2013

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

FDA Perspectives: Clinical Trial Regulatory Pathway for Renal Denervation Devices

Presenter: Andrew Farb

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Vessix (Boston Scientific)

Presenter: Ajay Kirtane

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Symplicity and Spyral (Medtronic)

Presenter: David Kandzari

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Paradise (ReCor Medical)

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: OneShot (Covidien)

Presenter: John Ormiston

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: EnligHTN (St. Jude)

Presenter: Stephen Worthley

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Cordis Renal Denervation Approach

Presenter: Marc Sapoval

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Allegro/Iberis (Angiocare/Terumo)

Presenter: Xiongjing Jiang

October 27, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

News Daily News

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

July 19, 2013

News Daily News

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

Caitlin E. Cox

July 05, 2013

News Daily News

EnligHTN I Publicado: La Denervación Renal con Catéter Multielectrodo es Segura y Eficaz

Caitlin E. Cox

July 05, 2013

News Daily News

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

June 28, 2013

News Daily News

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

June 28, 2013

Advertisement

Flash Lecture #2: Renal Denervation: Summary of Clinical Evidence

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

The Spectrum of Current and Future Renal Denervation Clinical Trials

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

FDA Perspectives: Clinical Trial Regulatory Pathway for Renal Denervation Devices

Device and Clinical Trial Update: Vessix (Boston Scientific)

Device and Clinical Trial Update: Symplicity and Spyral (Medtronic)

Device and Clinical Trial Update: Paradise (ReCor Medical)

Device and Clinical Trial Update: OneShot (Covidien)

Device and Clinical Trial Update: EnligHTN (St. Jude)

Device and Clinical Trial Update: Cordis Renal Denervation Approach

Device and Clinical Trial Update: Allegro/Iberis (Angiocare/Terumo)

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

EnligHTN I Publicado: La Denervación Renal con Catéter Multielectrodo es Segura y Eficaz

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content